Kostas Biliouris
Stock Analyst at BMO Capital
(0)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
VERV Verve Therapeutics | Downgrades: Market Perform | 20 14 | 11.3 | 19.47% | 3 | Jun 27, 2025 | |
ALNY Alnylam Pharmaceutic... | Maintains: Outperform | 300 360 | 322.64 | 11.58% | 5 | Jun 24, 2025 | |
SRPT Sarepta Therapeutics | Downgrades: Market Perform | 120 70 | 17.1 | 309.36% | 5 | Jun 16, 2025 | |
RCKT Rocket Pharmaceutica... | Maintains: Outperform | 30 8 | 2.52 | 217.46% | 2 | May 28, 2025 | |
RNA Avidity Biosciences | Initiates Coverage On: Outperform | 72 | 29 | 148.28% | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 9.59 | 421.38% | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 67 25 | 5.81 | 330.29% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 60 45 | 39.83 | 12.98% | 2 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 70 50 | 9.56 | 423.01% | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 34 34 | 4.3 | 690.7% | 3 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 35 | 13.14 | 166.36% | 6 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 22 17 | 1.5 | 1033.33% | 2 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 63 40 | 3.83 | 944.39% | 4 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 90 90 | 34.6 | 160.12% | 3 | Jul 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 120 120 | 11.98 | 901.67% | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 57 | 16.8 | 239.29% | 3 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | 37 | 44.85 | -17.5% | 1 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 102 100 | 55.12 | 81.42% | 4 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 19 | 2.42 | 685.12% | 1 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 98 49 | n/a | n/a | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 98 | 47.45 | 106.53% | 1 | Jun 17, 2022 |